Impact of Introducing Costs/Qaly Threshold on Access to Oncology Medicines in Slovakia

Value Health. 2014 Nov;17(7):A654-5. doi: 10.1016/j.jval.2014.08.2387. Epub 2014 Oct 26.

Authors

M Psenkova¹, S Mackovicova¹, D Tomek²

Affiliations

¹ Pharm-In Ltd, Bratislava, Slovak Republic.
² Slovak Medical University, Bratislava, Slovak Republic.

PMID: 27202368
DOI: 10.1016/j.jval.2014.08.2387

No abstract available